Clinical Trial: A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594769) titled 'A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults' on May 12.

Brief Summary: The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.

Study Start Date: May 18

Study Type: INTERVENTIONAL

Condition: Migraine

Intervention: DRUG: ODT2 Test formulation

Test Formulation

DRUG: ODT Reference formulation

Reference Formulation

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Pfizer

Published by HT Digital Content Servic...